302440 — SK Bioscience Co Share News
0.000.00%
Last trade - 00:00- KR₩3tn
- KR₩3tn
- KR₩651bn
Brief: SK Bioscience Applies For Conditional Approval For Its COVID-19 Vaccine Skycovione To EMA
Novavax surges on expanded COVID-19 vaccine deal with SK Biosciences
Brief: Sk Bioscience Co Ltd Wins 39 Billion Won Order From Novavax Inc
Novavax hits 3-month high as EU clears partner for COVID vaccine supply
Brief: Novavax Says EMA Approves SK Bioscience As A Supplier Of Novavax Nuvaxovid Covid-19 Vaccine
S.Korea approves first domestically developed COVID vaccine
GSK and SK bioscience's COVID vaccine submitted for S.Korea approval
Covid Science: Antibodies in children last at least 6 mos after COVID; SK Bioscience vaccine shows promise vs Omicron (updated)
Covid Science: Most unvaccinated children lack antibodies after COVID; GSK vaccine shows promise vs Omicron
S.Korea to buy 10 million doses of SK Bioscience's COVID vaccine (updated)
S.Korea reaches deal to buy 10 million doses of SK Bioscience's COVID vaccine -KDCA
South Korea authorises use of Novavax COVID-19 vaccine (updated)
Brief: SK Bioscience Signs Supply Contracts Worth $172 Million With Novavax
S.Korea extends social distancing curbs as COVID-19 cases rise in Seoul
Vaccine makers should supply shots for trials to help spur sector -CEPI (updated)
Vaccine makers should supply shots for trials to help spur sector -CEPI
Press Digest: Financial Times - Sept 1
UK Stocks-Factors to watch on Aug 31 (updated)
GSK, SK Bioscience to test COVID-19 vaccine against AstraZeneca shot (updated)